Global Research Antibodies Market size is expected to reach USD 4.30 billion by 2025. Antibodies are secreted immunoglobin molecules mainly produced by plasma cells. They are a part of the body’s immune system. The normal function of antibodies is to latch onto antigens and flag them for destruction, thus helping to fight infection. The market is driven by increasing R&D collaborations among various private & public organizations to promote technical advancements in disease progression and product development activities. The market size is expected to expand at a CAGR of 6.1% in the upcoming period.
In research antibodies, some technologies are used such as Immunohistochemistry, Western Blotting, Immunofluorescence, Immunoprecipitation, Flow Cytometry, ELISA, and others. The “western blotting” segment held largest market share in 2016 and is expected to hold the highest market share in the upcoming period due to growing prevalence of diseases with limited treatment options such as HIV. Western blotting is used in research activities conducted by pharmaceutical & biotechnology companies as well as academic institutes.
Product type such as primary and secondary could be explored in research antibodies industry. Primary antibodies were the most leading product type in 2016 due to greater specificity leading to increased adoption in research activities. The segment is anticipated to grow at the highest CAGR during the forecast period owing to the increasing adoption of reagents containing primary research antibodies due to its related benefits such as greater specificity, easy availability and suitability to various research needs.
Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/research-antibodies-market/request-sample
The factors that play an important role in the growth of research antibodies market include increasing demand, growing population, increasing urbanization & industrialization, increasing funding for proteomics research & drug discovery, growing R&D activities & expenditure in the life science industry, increasing demand for personalized medicine & protein therapeutics, technological advancements and stringent government rules & regulations. Moreover, increasing prevalence of breast cancer and rising need for personalized medicine is stirring up the demand for advanced techniques, which is creating ample growth of the market.
However, the quality concerns over research antibodies, time & cost intensive antibody development processes and the pricing pressures faced by market players are negatively impacting the growth of research antibodies industry. The market is widely analyzed based on different regional factors such as gross domestic product (GDP), demographics, acceptance, inflation rate and others. The market is categorized based on product, type, technology, source, application, end-use and geography.
The market is classified into type such as monoclonal antibodies, polyclonal antibodies, and others. The “monoclonal antibodies” accounted for the leading share in 2016 and is anticipated to grow at a high CAGR in the next couple of years. Significantly rising number of research activities in genomics that require technologically advanced genetic platforms has led to increase the demand for monoclonal antibodies.
North America held largest market share in 2016 due to presence of many biopharmaceutical & biotechnology manufacturers and academic institutes coupled with huge economic development. Asia Pacific is expected to hold the highest market share in the forthcoming years. The growing population, booming healthcare industry, increasing innovation in antibody production and improving healthcare infrastructure coupled with regulatory policies implemented by public healthcare organizations to enhance safety are major factors driving the growth of the market in this region.
The key players contributing to the robust development of the research antibodies market include Abcam PLC, Agilent Technologies, Thermo Fisher Scientific Inc., Merck Group, Becton, Dickinson and Company, Cell Signaling Technology Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, GenScript, Danaher Corporation, PerkinElmer Inc., Genscript, BioLegend Inc. and Lonza. These market players are focusing on inorganic growth to sustain themselves amidst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Access Full Research Report @
https://www.millioninsights.com/industry-reports/research-antibodies-market
Factors such as the increasing R activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and the growing collaboration between industries and academic institutes are the key drivers of the research antibodies market.The Research Antibodies Market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793Market Segmentation:-On the basis of product, the reagents segment accounted for the largest share of the global research antibodies market (including reagents), in 2016.
This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques.Based on technology, the western blotting segment accounted for the largest share of the Research Reagents Market.
Its ability to quantify as little as 0.1 nanograms of protein in a sample with high specificity makes it an indispensable tool in proteomic research; this is the key factor driving market growth.Based on application, the proteomics segment accounted for the largest share of the Research Reagents Market.
The large share of this segment is attributed to the deployment of proteomic-based approaches in biomarker detection and cancer profiling, increasing R expenditure, and availability of funds from various organizations.Based on end user, the pharmaceutical & biotechnological companies segment accounted for the largest share of the Research Antibodies and Reagents Market owing to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the ever-developing proteomics research sector.Key Market Opportunities: - 1 High Growth Opportunities in Emerging Markets 2 Increasing Demand for Personalized Medicine and Protein Therapeutics 3 Growths in Stem Cell and Neurobiology Research 4 Increasing Focus on Biomarker DiscoveryRegional Analysis:-North America accounted for the largest share of the Research Antibodies and Reagents Market in 2016, followed by Europe.
This regional segment shows significant market growth opportunities owing to the increasing research activities in the fields of proteomics and genomics, favorable government funding initiatives, and the growing focus of stakeholders on research projects.Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94212793Top Key Players:-The major players in the research antibodies market (including reagents) are Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany), Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.).
